Predictors of surgical outcomes in patients with drug-resistant temporal lobe epilepsy

Aim. To identify predictors of surgical outcomes in patients with drug-resistant temporal lobe epilepsy in a multivariate model.

Materials and methods. Aretrospective study included 69 patients with drug-resistant temporal lobe epilepsy who underwent microsurgical anterior temporal lobectomy. The study included 31 (45%) men and 38 (55%) women. The median age was 28 (21; 36). Surgical treatment outcomes were assessed at 6, 12, 36, and 60 months after surgical intervention according to the Engel Epilepsy Surgery Outcome Scale. Logistic regression equations were calculated, a ROC curve was constructed, and odds ratio (OR) with 95% confidence interval (CI), sensitivity, specificity, area under the ROC curve (AUC) were calculated.

Results. In all assessed time periods, 88.3–93.0% of patients had outcomes consistent with Engel classes I and II. The distribution of patients by outcome classes did not change statistically significantly over the entire follow-up period. There were the following predictors of high efficacy of surgical treatment at 6 months after surgery: relatively shorter duration of active disease course (OR 0.719, 95%, CI: 0.437–0.966, p < 0.05), absence of status epilepticus (OR 0.048, 95% CI: 0.002–0.472, p < 0.05), absence of subdominant foci of irritative activity (OR 0.123, 95% CI: 0.012–0.845, p < 0.01), presence of mesial temporal sclerosis (OR 1008, 95% CI: 21.59–1310851, p < 0.01), a relatively longer resection margin on the temporal lobe (OR 637.32, 95% CI: 5.43–1960062, p < 0.05), lateralization of epileptogenic zone in subdominant hemisphere (OR 0.103, 95% CI 0.004–0.937, p = 0.0532). AUC was 0.957 (0.917–0.997), p < 0.0001; sensitivity 87.5%, and specificity 82.8%.

Conclusion. Independent predictors of the efficacy of microsurgical anterior temporal lobectomy in patients with drug-resistant temporal lobe epilepsy are the following: shorter duration of active disease course, absence of status epilepticus in the history, absence of subdominant foci, presence of mesial temporal sclerosis, a relatively longer resection margin on the temporal lobe, and lateralization of the epileptogenic zone in the temporal lobe of the subdominant hemisphere.

1. Guekht A., Hauser W.A., Milchakova L., et al. The epidemiology of epilepsy in the Russian Federation. Epilepsy Res. 2010 Dec; 92(2–3): 209–218. https://doi.org/10.1016/j.eplepsyres.2010.09.011. Epub 2010 Oct 28. PMID: 21035312.

2. Falco-Walter J. Epilepsy-Definition, Classification, Pathophysiology, and Epidemiology. Semin Neurol. 2020 Dec; 40(6): 617–623. https://doi.org/10.1055/s-0040-1718719. Epub 2020 Nov 5. PMID: 33155183.

3. Pitkänen A., Ekolle Ndode-Ekane X., Lapinlampi N., Puhakka N. Epilepsy biomarkers – Toward etiology and pathology specificity. Neurobiol Dis. 2019 Mar; 123: 42–58. https://doi.org/10.1016/j.nbd.2018.05.007. Epub 2018 May 18. PMID: 29782966.

4. Fattorusso A., Matricardi S., Mencaroni E., et al. The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies. Front Neurol. 2021 Jun 22; 12: 674483. https://doi.org/10.3389/fneur.2021.674483. PMID: 34239494.

5. Janmohamed M., Brodie M.J., Kwan P. Pharmacoresistance – Epidemiology, mechanisms, and impact on epilepsy treatment. Neuropharmacology. 2020 May 15; 168: 107790. https://doi.org/10.1016/j.neuropharm.2019.107790. Epub 2019 Sep 24. PMID: 31560910.

6. Thijs R.D., Surges R., O’Brien T.J., Sander J.W. Epilepsy in adults. Lancet. 2019 Feb 16; 393(10172): 689–701. https://doi.org/10.1016/S0140-6736(18)32596-0. Epub 2019 Jan 24. PMID: 30686584.

7. Jobst B.C., Cascino G.D. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015 Jan 20; 313(3): 285–293. https://doi.org/10.1001/jama.2014.17426. PMID: 25602999.

8. Cramer S.W., McGovern R.A., Wang S.G., et al. Resective epilepsy surgery: assessment of randomized controlled trials. Neurosurg Rev. 2021 Aug; 44(4): 2059–2067. https://doi.org/10.1007/s10143-020-01432-x. Epub 2020 Nov 9. PMID: 33169227.

9. West S., Nolan S.J., Newton R. Surgery for epilepsy: a systematic review of current evidence. Epileptic Disord. 2016 Jun 1; 18(2): 113–121. https://doi.org/10.1684/epd.2016.0825. PMID: 27193634.

10. Matern T.S., DeCarlo R., Ciliberto M.A., Singh R.K. Palliative Epilepsy Surgery Procedures in Children. Semin Pediatr Neurol. 2021 Oct; 39: 100912. https://doi.org/10.1016/j.spen.2021.100912. Epub 2021 Aug 19. PMID: 34620461.

11. Vaddiparti A., Huang R., Blihar D., et al. The Evolution of corpus callosotomy for epilepsy management. World Neurosurg. 2021 Jan; 145: 455–461. https://doi.org/10.1016/j.wneu.2020.08.178. Epub 2020 Sep 2. PMID: 32889189.

12. Madaan P., Gupta A., Gulati S. Pediatric epilepsy surgery: indications and evaluation. Indian J Pediatr. 2021 Oct; 88(10): 1000–1006. https://doi.org/10.1007/s12098-021-03668-x. Epub 2021 Mar 19. PMID: 33740232.

13. Graham D., Tisdall M.M., Gill D. Corpus callosotomy outcomes in pediatric patients: A systematic review. Epilepsia. 2016 Jul; 57(7): 1053–1068. https://doi.org/10.1111/epi.13408. Epub 2016 May

14. Bello-Espinosa L.E., Olavarria G. Epilepsy surgery in children. Pediatr Clin North Am. 2021 Aug; 68(4): 845–856. https://doi.org/10.1016/j.pcl.2021.04.016. PMID: 34247713.

15. Ryvlin P., Rheims S., Hirsch L.J., et al. Neuromodulation in epilepsy: state-of-the-art approved therapies. Lancet Neurol. 2021 Dec; 20(12): 1038–1047. https://doi.org/10.1016/S1474-4422(21)00300-8. Epub 2021 Oct 25. Erratum in: Lancet Neurol. 2021 Dec;20(12):e7. PMID: 34710360.

16. Asadi-Pooya A.A., Rostami C. History of surgery for temporal lobe epilepsy. Epilepsy Behav. 2017 May; 70(Pt A): 57–60. https://doi.org/10.1016/j.yebeh.2017.02.020. Epub 2017 Apr 12. PMID: 28410466.

17. West S., Nevitt S.J., Cotton J., et al. Surgery for epilepsy. Cochrane Database Syst Rev. 2019 Jun 25;6(6):CD010541. https://doi.org/10.1002/14651858.CD010541.pub3. PMID: 31237346.

18. Muhlhofer W., Tan Y.L., Mueller S.G., Knowlton R. MRI-negative temporal lobe epilepsy-What do we know? Epilepsia. 2017 May; 58(5): 727–742. https://doi.org/10.1111/epi.13699. Epub 2017 Mar 7. PMID: 28266710.

19. Krucoff M.O., Chan A.Y., Harward S.C., et al. Rates and predictors of success and failure in repeat epilepsy surgery: A meta-analysis and systematic review. Epilepsia. 2017 Dec; 58(12): 2133–2142. https://doi.org/10.1111/epi.13920. Epub 2017 Oct 10. PMID: 28994113.

20. de Tisi J., Bell G.S., Peacock J.L., et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011 Oct 15; 378(9800): 1388–1395. https://doi.org/10.1016/S0140-6736(11)60890-8. PMID: 22000136.

21. Fisher R.S., Cross J.H., French J.A., et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr; 58(4): 522–530. https://doi.org/10.1111/epi.13670. Epub 2017 Mar 8. PMID: 28276060.

22. Tatum W.O., Rubboli G., Kaplan P.W., et al. Clinical utility of EEG in diagnosing and monitoring epilepsy in adults. Clin Neurophysiol. 2018 May; 129(5): 1056–1082. https://doi.org/10.1016/j.clinph.2018.01.019. Epub 2018 Feb 1. PMID: 29483017.

23. Jayakar P., Gotman J., Harvey A.S., et al. Diagnostic utility of invasive EEG for epilepsy surgery: Indications, modalities, and techniques. Epilepsia. 2016 Nov; 57(11): 1735–1747. https://doi.org/10.1111/epi.13515. Epub 2016 Sep 28. PMID: 27677490.

24. Bernasconi A., Cendes F., Theodore W.H., et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019 Jun; 60(6): 1054–1068. https://doi.org/10.1111/epi.15612. Epub 2019 May 28. PMID: 31135062.

25. Gross R.E., Boulis N.M. Neurosurgical operative atlas: functional neurosurgery. 3d ed. New-York: Thieme/AANS, 2018. 362 p. ISBN-10: 9781626231115.

26. Engel J.Jr., Van Ness P.C., Rasmussen T.B., Ojemann L.M. Outcome with respect to epileptic seizures. In: Engel Jr.J. (Ed.), Surgical Treatment of the Epilepsies, 2nd Ed. Raven Press: New York, 1993. P. 609–621. ISBN-10: 0881679887

27. Giulioni M., Marucci G., Martinoni M., et al. Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications. J Neurosurg. American Association of Neurological Surgeons; 2013; 119: 37–47. https://doi.org/10.3171/2013.3.JNS122132. PMID: 23641822.

28. Barba C., Giometto S., Lucenteforte E., et al. Seizure outcome of temporal lobe epilepsy surgery in adults and children: A systematic review and meta-analysis. Neurosurgery. 2022 Nov 1; 91(5): 676–683. https://doi.org/10.1227/neu.0000000000002094. Epub 2022 Aug 16. PMID: 35960753

29. Mohan M., Keller S., Nicolson A., et al. The long-term outcomes of epilepsy surgery. PLoS One. 2018 May 16 13(5): e0196274. https://doi.org/10.1371/journal.pone.0196274. PMID: 29768433.

30. Hemb M., Palmini A., Paglioli E., et al. An 18-year follow-up of seizure outcome after surgery for temporal lobe epilepsy and hippocampal sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2013; 84: 800–805. https://doi.org/10.1136/jnnp-2012-304038 PMID: 23408065

31. Alexandratou I., Patrikelis P., Messinis L., et al. Long-term neuropsychological outcomes following temporal lobe epilepsy surgery: An update of the literature. Healthcare (Basel). 2021 Sep 3; 9(9): 1156. https://doi.org/10.3390/healthcare9091156. PMID: 34574930; PMCID: PMC8466433.

32. Polkey C.E. Clinical outcome of epilepsy surgery. Curr Opin Neurol. 2004 Apr; 17(2): 173–178. https://doi.org/10.1097/00019052-200404000-00015. PMID: 15021245.